Update on rhinitis and rhinosinusitis.
allergic rhinitis
children
chronic rhinosinusitis
Journal
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
ISSN: 1399-3038
Titre abrégé: Pediatr Allergy Immunol
Pays: England
ID NLM: 9106718
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
15
10
2019
accepted:
17
10
2019
entrez:
5
2
2020
pubmed:
6
2
2020
medline:
15
12
2020
Statut:
ppublish
Résumé
Rhinitis is a common, under-diagnosed condition in childhood and adolescence. Pathogenic classification of rhinitis includes allergic rhinitis (AR) and non-allergic rhinitis (NAR); the latter is characterized by non-infectious and infectious subtypes; non-infectious subtype is by far the most prevalent in infancy. Endotyping may help to predict chronic rhinosinusitis (CRS) risk factors, as well as disease progression and response to different treatments. The validation of pediatric algorithms and the implementation of novel biotherapeutics in the endotype-driven integrated pathways of CRS will lead in the next future to more successful disease management.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
32-33Informations de copyright
© 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.
Références
Bosquet J, Hellings PW, Agache I, et al. C Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology. J Allergy Clin Immunol. 2019;143(3):864-879.
Badr DT, Gaffin JM, Phipatanakul W. Pediatric Rhinosinusitis. Curr Treat Options Allergy. 2016;3(3):268-281.
Brook I. The role of antibiotics in pediatric chronic rhinosinusitis. Laryngoscope Investig Otolaryngol. 2017;2(3):104-108.
Brietzke SE, Shin JJ, Choi S, et al. Clinical consensus statement: pediatric chronic rhinosinusitis. Otolaryngol Head Neck Surg. 2014;151(4):542-553.
Bachert C, Hellings ZN, PW, Bousquet J, MD. . Endotype-driven care pathways in patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2018;141:1543-1551.
Fokkens WJ, Reitsma S. Proposal for an Algorithm on the management of chronic rhinosinusitis. Allergy. 2019;74(7):1415-1416.
Gurrola J, Borish L. Chronic rhinosinusitis: endotypes, biomarkers, and treatment response. J Allergy Clin Immunol. 2017;140:1499-1508.
Jonstam K, Swanson BN, Mannet LP, et al. Dupilumab reduces local type 2 pro-inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis. Allergy. 2019;74:743-752.
Zicari AM, Celani C, De Castro G, De Biase V, Duse M. Anti IgE antibody as treatment of allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis. Eur Rev Med Pharmacol Sci. 2014;18(13):1839-1841.
M1, Caminiti S, Zicari AM. . Rhinosinusitis: prevention strategies. Ped Allergy Immunol. 2007;18(s18):71-74.